Get started
Author

Roberto Camerini

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings
2002 · Filiberto Belli, Alessandro Testori, et al. · Journal of Clinical Oncology · 387
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
2003 · Vincenzo Mazzaferro, Jorgelina Coppa, et al. · PubMed · 240
Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells
2003 · Licia Rivoltini, Chiara Castelli, et al. · The Journal of Immunology · 119
PDF
Current adjuvants and new perspectives in vaccine formulation
2011 · Emanuele Montomoli, Simona Piccirella, et al. · Expert Review of Vaccines · 110
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases
2021 · Anna Maria Di Giacomo, Vanna Chiarion-Sileni, et al. · Clinical Cancer Research · 77
PDF
Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
2010 · Michele Maio, Andrzej Mackiewicz, et al. · Journal of Clinical Oncology · 67
Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats
1993 · Basilia Zingarelli, Francesco Squadrito, et al. · Inflammation Research · 65
Historical review of thymosin α 1 in infectious diseases
2015 · Roberto Camerini, Enrico Garaci · Expert Opinion on Biological Therapy · 51
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
2024 · Anna Maria Di Giacomo, Vanna Chiarion-Sileni, et al. · European Journal of Cancer · 43
PDF
Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature
2014 · Maria Giovanna Scioli, Maria Antonietta Stasi, et al. · Clinical and Translational Gastroenterology · 38
Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment
2011 · T. L. Mikhailova, E. Sishkova, et al. · Alimentary Pharmacology & Therapeutics · 38
PDF
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
2021 · Simone Lanini, Stefania Capone, et al. · Science Translational Medicine · 34
PDF
Historical review on thymosin α1 in oncology: preclinical and clinical experiences
2015 · Enrico Garaci, Francesca Pica, et al. · Expert Opinion on Biological Therapy · 34
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study
2011 · G. Carraro, A. Naso, et al. · Vaccine · 30
Thymosin α1 continues to show promise as an enhancer for vaccine response
2012 · Cynthia Tuthill, Israel Rios, et al. · Annals of the New York Academy of Sciences · 29
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy
2018 · Riccardo Danielli, Filomena Cisternino, et al. · Expert Opinion on Biological Therapy · 27
784 – Velusetrag Improves Gastoparesis Both in Symptoms and Gastric Emptying in Patients with Diabetic Or Idiopathic Gastroparesis in a 12-Week Global Phase 2B Study
2019 · Thomas Abell, Braden Kuo, et al. · Gastroenterology · 24
PDF
Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
2012 · A. Ciancio, P. Andreone, et al. · Journal of Viral Hepatitis · 23
The effect of thymosin treatment of venous ulcers
2010 · G. Guarnera, A. DeRosa, et al. · Annals of the New York Academy of Sciences · 22
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
2021 · Chiara Agrati, Stefania Capone, et al. · npj Vaccines · 15
PDF
Thymosin β‐4 and Venous Ulcers
2007 · GIORGIO GUARNERA, ALFONSO DE ROSA, et al. · Annals of the New York Academy of Sciences · 15
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
2023 · Stefania Capone, Francesco M. Fusco, et al. · Cell Reports Medicine · 13
PDF
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
2021 · Michele Maio, Michael Lahn, et al. · Journal of Experimental & Clinical Cancer Research · 10
PDF
A large first-line, randomized, dose-finding, phase II study on thymosin-alpha 1 (T-alpha 1) plus dacarbazine (DTIC) with or without interferon-alpha (IFN-alpha) compared to DTIC plus IFN-alpha in stage IV melanoma. Tumor response and survival results
2007 · R. Camerini, A. Mackiewicz, et al. · Journal of Clinical Oncology · 10
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
2022 · Chiara Agrati, Concetta Castilletti, et al. · npj Vaccines · 9
PDF
Works count: 48
Citation count: 1,549
H-index: 19
I10-index: 24
Year
Topic
Type